Synthesis, cancericidal and antimicrotubule activities of 3-(haloacetamido)-benzoylureas

Anti-Cancer Drug Design

Volumn 13, Issue 7, 1998, Pages 735-747

  Jiang, Jian Dong ^a   Roboz, John ^a   Weisz, Imre ^a   Deng, Lin ^a   Ma, Longhua ^a   Holland, James F ^a   Bekesi, J George ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

3 (Haloacetamido) benzoylureas; Antimicrotubular; Antitumor; Apoptosis; Synthesis

Indexed keywords

3 AMINOBENZOIC ACID; ANTINEOPLASTIC AGENT; TRIFLUOROACETIC ACID; UREA DERIVATIVE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKEMIA P 388; MALE; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICROTUBULES; MITOSIS; TUMOR CELLS, CULTURED; UREA;

ANIMALIA;

EID: 0031708738     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. ABE, M., MIYAKI, K., MIZUNO, D., NARITA, N., TAKEUCHI, T., UKITA, T & YAMAMOTO, T (1959). The Cell agar plate screening for antitumor cell effect. 1. Screening results of 1300 organic compounds. Japanese Journal of Medicinal Science and Biology, 12, 175.
2. ALBERTS, B., BRAY, D., LEWIS, I., RAFF, M., ROBERTS, K. & WATSON, J.D. (1994). The mechanics of cell division. In Molecular Biology of The Cell. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K. & Watson, J.D. (eds), p. 911. Garland: New York.
3. BAKER, B. & DEVAN, B.P. (1989). Sequence-specific cleavage of DNA by N-bromoacetyldistamycin. Product and kinetic analysis. Journal of the American Chemistry Society, 111, 2700.
4. BUDESINSKY, Z., EMR, A., MUSIUL, V. PERINA, Z. & ZIKMUND, (1959). Synthetic antidiabetics. I. Derivatives of urea, thiourea, and guanidine. Ceskoslovenska Farmacie (Praha), 8, 129.
5. CHEN, K., KUO, S.C., HSIEH, M.C., MAUGER, A., LIN, C.M., HAMEL, E. & LEE, K.H. (1997). Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1H)-ones as antitumor agents that inhibit tubulin polymerization. Journal of Medicinal Chemistry, 40, 3049.
6. ERKELL, L.J. & WALUN, E. (1979). Differentiation of cultured neuroblastoma cells by urea derivatives. FEBS Letters, 104, 401.
7. HARGREAVES, A.J., GLAZIER, A.P., FLASKOS, J., MULLINS, F.H & MCLEAN, W.G. (1994). The disruption of brain microtubules in vitro by the phospholipase inhibitor p-boromophenacyl bromide. Biochemical Pharmacology, 47, 1137.
8. HATFILL, S J., FESTER,E.D., DeBEER, O.P. & BOHM, L. (1991). Induction of morphological differentiation in the human leukemic cell line K562 by exposure to thalidomide metabolites. Leukemia Research, 15, 129.
9. HOTZ, M., TRAGANOS, F. & DARZYNKIEWICZ, Z. (1992). Changes in nuclear chromatin related to apoptosis and necrosis induced by the DNA topoisomerase II inhibitor fostriecin in Molt-4 and HL-60 cells are revealed by altered DNA sensitivity to denaturation. Experimantal Cell Research, 201, 184.
10. JENKINS, VK , JUNEJA, H.S., IVES, K., LEE, S, & PERRY, R.R. (1993). Effects of diflubenzuron and clanfenur on mouse bone marrow cells. Investigations of New Drugs, 11, 279.
11. LUDUENA, R F. & ROACH, M.C. (1991). Tubulin sulfhydryl groups as probes and targets for antimitotic and anti micro tubule agents. Pharmacological Therapeutics, 49 133.
12. MALAWISTA, S.E., BENSCH, K.G. & SATO, H. (1968). Vinblastine and griseofulvin reversibly disrupt the living mitotic spindle. Science, 160, 770.
13. MILAM, K.M. & CLEAVER, J.E (1984). Inhibitors of poly(adonisine diphosphate-ribose) synthesis: effect on other metabolic processes. Science, 223, 589.
14. MILAS, L., HUNTER, R H, KURDOGLU, B., MASON, K.A., MEYN, R., STEPHENS, L C. & PETERS, L.J. (1995). Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumor treated with taxol. Cancer Chemotherapy and Pharmacology, 35, 297.
15. ROBOZ, J, JIANG, J.D., HOLLAND, J.F. & BEKESI G.J. (1997). Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroetheyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide. Cancer Research, 57, 4795.
16. SCHIFF, PB., FANT, J. & HORWITZ, S.B. (1979). Promotion of microtubule assembly in vitro by taxol. Nature, 277, 665.
17. SHERR, C.J (1996). Cancer cell cycle. Science, 274, 1672.
18. SHI, Y., GLYNN, J.M., GUILBERT, L.J., COTTER, TG., BISSONNETTE, R P., & GREEN, D R. (1992). Role for C-myC in apoptotic cell death in T-cell hybridoma. Science, 257, 212.
19. SKINNER, W.A. & SCHOLLER, J (1967). Anticancer activity of alkylating agents derived from various diamines and diols on Ehrlich ascites carcinoma. Cancer Chemotherapy Reports, 51, 205.
20. TAKANO, Y, OKUDAIRA, M. & HARMON, B.V. (1993). Apoptosis induced by microtubule disrupting drugs in cultured human lymphoma cells. Inhibitory effects of phorbol ester and zinc sulphate. Pathology Research and Practice, 189, 197.
21. UTSUMI, H. & ELKIND, M M. (1994). Inhibtors of poly(ADP-ribose) synthesis inhibit the two types of repair of potentially lethal demage. International Journal of Radiation Oncology Biology Physics, 29, 577.
22. WEISZ, I. & OTVOS, L. (1985). Acylierung von Alkoholen, Aminen und Amine-Saltzen mit Saueren-kloriden in Gegenwart von Amiden. Archiv der Pharmazie (Weinheim, Germany), 318, 766.
23. WEISZ, I., DUDAS, J., GRIBOVSZKI, P. GREGA, I, HAVLEKA, F., KEREKES, F, MARASVÖLGYI, S., PINTER, Z. & SZIĹAGYI, G.Y. (1978). N-Substituted carbamate esters and carboxamides. Patent HU 14225. Chemical Abstracts, 88, 152278.
24. WEISZ, I., ROBOZ, J. & BEKESI, J. G. (1996 ). Acidic coupling and aminolytic TFA cleavage approaches in a new synthesis of L-m-sarcolysin containing antitumor tripeptide ester. Tetrahedron Letters, 37, 563.